Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.470
-0.100 (-6.37%)
At close: Mar 28, 2025, 4:00 PM
1.510
+0.040 (2.72%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Atai Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 17.51 | 45.03 | 190.61 | 362.27 | 97.25 | Upgrade
|
| Short-Term Investments | 44.83 | 134.22 | 82.5 | - | - | Upgrade
|
| Cash & Short-Term Investments | 62.33 | 179.26 | 273.11 | 362.27 | 97.25 | Upgrade
|
| Cash Growth | -65.23% | -34.36% | -24.61% | 272.52% | 223.48% | Upgrade
|
| Other Receivables | 1.35 | 1.75 | 5.63 | 5.41 | 1.07 | Upgrade
|
| Receivables | 1.35 | 2.26 | 5.63 | 6.32 | 1.29 | Upgrade
|
| Prepaid Expenses | 0.77 | 1.41 | 2.03 | 3.05 | 0.14 | Upgrade
|
| Restricted Cash | 10 | - | - | - | - | Upgrade
|
| Other Current Assets | 5.68 | 2.67 | 6.37 | 3.45 | 0.87 | Upgrade
|
| Total Current Assets | 80.13 | 185.59 | 287.15 | 375.08 | 99.55 | Upgrade
|
| Property, Plant & Equipment | 3.87 | 2.2 | 1.15 | 0.15 | 0.07 | Upgrade
|
| Long-Term Investments | 70.97 | 91.66 | 6.76 | 27.76 | 8.04 | Upgrade
|
| Goodwill | 0.33 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 3.25 | 1.77 | - | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 1.58 | Upgrade
|
| Other Long-Term Assets | 0.85 | 0.95 | 3.13 | 7.34 | 0.34 | Upgrade
|
| Total Assets | 159.39 | 293.48 | 305.44 | 414.17 | 111.55 | Upgrade
|
| Accounts Payable | 2.62 | 4.59 | 2.4 | 6 | 3.08 | Upgrade
|
| Accrued Expenses | 9.66 | 14.54 | 15.08 | 6.69 | 8.22 | Upgrade
|
| Current Portion of Long-Term Debt | 9.36 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.48 | 0.28 | 0.18 | - | - | Upgrade
|
| Current Income Taxes Payable | 0.19 | 0.72 | 2.22 | 8.14 | 1 | Upgrade
|
| Other Current Liabilities | 2.65 | - | 0.01 | 0.1 | - | Upgrade
|
| Total Current Liabilities | 24.95 | 20.12 | 19.9 | 20.94 | 12.3 | Upgrade
|
| Long-Term Debt | 16.33 | 20.08 | 17.52 | 3.14 | 2.18 | Upgrade
|
| Long-Term Leases | 0.73 | 0.99 | 0.04 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.82 | 7.98 | 2.22 | 4.13 | 1.71 | Upgrade
|
| Total Liabilities | 42.83 | 49.16 | 39.68 | 28.21 | 16.18 | Upgrade
|
| Common Stock | 18.79 | 18.57 | 18.56 | 18 | 13.37 | Upgrade
|
| Additional Paid-In Capital | 816.19 | 794.79 | 774.09 | 725.05 | 261.63 | Upgrade
|
| Retained Earnings | -700.21 | -550.94 | -510.19 | -357.8 | -190 | Upgrade
|
| Comprehensive Income & Other | -18.47 | -19.46 | -21.73 | -8.34 | 5.82 | Upgrade
|
| Total Common Equity | 116.3 | 242.96 | 260.74 | 376.91 | 90.82 | Upgrade
|
| Minority Interest | 0.26 | 1.35 | 5.03 | 9.05 | 4.55 | Upgrade
|
| Shareholders' Equity | 116.55 | 244.32 | 265.77 | 385.96 | 95.37 | Upgrade
|
| Total Liabilities & Equity | 159.39 | 293.48 | 305.44 | 414.17 | 111.55 | Upgrade
|
| Total Debt | 26.91 | 21.34 | 17.74 | 3.14 | 2.18 | Upgrade
|
| Net Cash (Debt) | 35.42 | 157.92 | 255.37 | 359.12 | 95.07 | Upgrade
|
| Net Cash Growth | -77.57% | -38.16% | -28.89% | 277.75% | 217.90% | Upgrade
|
| Net Cash Per Share | 0.22 | 0.99 | 1.64 | 2.60 | 1.02 | Upgrade
|
| Filing Date Shares Outstanding | 198.31 | 166.03 | 166.01 | 160.71 | 11.47 | Upgrade
|
| Total Common Shares Outstanding | 167.96 | 166.03 | 165.94 | 160.68 | 11.47 | Upgrade
|
| Working Capital | 55.17 | 165.47 | 267.25 | 354.15 | 87.25 | Upgrade
|
| Book Value Per Share | 0.69 | 1.46 | 1.57 | 2.35 | 7.92 | Upgrade
|
| Tangible Book Value | 112.72 | 241.19 | 260.74 | 376.91 | 90.82 | Upgrade
|
| Tangible Book Value Per Share | 0.67 | 1.45 | 1.57 | 2.35 | 7.92 | Upgrade
|
| Machinery | 2.93 | 1.13 | - | - | - | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.